Predictors of edge stenosis after paclitaxel-eluting stent implantation

被引:3
|
作者
Kang, Woong Chol [1 ]
Park, Yae Min [1 ]
Shin, Kwen-Chul [1 ]
Moon, Chan Il [1 ]
Shin, Mi Seung [1 ]
Lee, Kyounghoon [1 ]
Han, Seung Hwan [1 ]
Ahn, Taehoon [1 ]
Shin, Eak Kyun [1 ]
机构
[1] Gachon Univ Med & Sci, Dept Cardiol, Gil Hosp, Inchon 405760, South Korea
关键词
edge stenosis; intravascular ultrasound; paclitaxel-eluting stent; SERIAL INTRAVASCULAR ULTRASOUND; TAXUS-II TRIAL; INTIMAL HYPERPLASIA; CORONARY INTERVENTIONS; DIABETES-MELLITUS; RESTENOSIS; RESPONSES; ANGIOPLASTY; BALLOON; IMPACT;
D O I
10.1097/MCA.0b013e328343fbff
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background Although edge stenosis (ES) is a main limitation of drug-eluting stents, the predictors for ES are not well known. We evaluated the predictors for ES after paclitaxel-eluting stent implantation. Methods One hundred and eleven angina patients (64 men; 62.2 +/- 8.4 years of age) were divided into ES (n = 9) and non-ES groups (n = 102). The clinical findings, procedural factors, and intravascular ultrasound (IVUS) parameters were analyzed. Results Although clinical characteristics were not different between groups, diabetes mellitus (DM) was more common in the ES group (P = 0.002). The vessel, plaque, and lumen areas of the lesions were not different between groups; however, the vessel area of the proximal and distal reference artery was smaller in the ES group. Lesions with positive remodeling were more common in the ES group (P = 0.015). On the basis of univariate analysis, predictors of ES included DM, lesions with positive remodeling, IVUS parameters, and procedural factors. After adjusting for clinical findings, angiographic factors, and IVUS parameters, the presence of DM [odds ratio (OR): 9.20; 95% confidence interval (CI): 1.40-60.62, P = 0.021] and lesions with positive remodeling (OR: 5.93; 95% CI: 1.13-31.02, P = 0.035) were independent predictors of ES. The lumen area in the distal 1mm reference segment was a protective factor for ES (OR: 0.05; 95% CI: 0.00-0.74, P = 0.029). Conclusion The risk of ES after paclitaxel-eluting stent implantation was higher in patients who had DM and lesions with positive remodeling. Of the IVUS parameters, the lumen area in the distal 1 mm reference segment was a protective factor against ES. Coron Artery Dis 22:59-63 (C) 2011 Wolters Kluwer Health vertical bar Lippincott Williams & Wilkins.
引用
收藏
页码:59 / 63
页数:5
相关论文
共 50 条
  • [21] Comparison of Peri-Stent Vascular Response After Sirolimus and Paclitaxel-Eluting Stent Implantation
    Kim, Myeong Gun
    Kang, Woong Chol
    Shin, Kwen Chul
    Park, Yae Min
    Lee, Kyounghoon
    Han, Seung Hwan
    Ahn, Taehoon
    Shin, Eak Kyun
    AMERICAN JOURNAL OF CARDIOLOGY, 2011, 107 (8A): : 78A - 78A
  • [22] Outcomes of paclitaxel-eluting stent implantation in patients with stenosis of the left anterior descending coronary artery
    Dangas, G
    Ellis, SG
    Shlofmitz, R
    Katz, S
    Fish, D
    Martin, S
    Mehran, R
    Russell, ME
    Stone, GW
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2005, 45 (08) : 1186 - 1192
  • [23] Local persistent hypercoagulability after drug-eluting stent implantation: sirolimus-eluting stent vs. paclitaxel-eluting stent
    Yamaguchi, K.
    Wakatsuki, T.
    Niki, T.
    Kusunose, K.
    Koshiba, K.
    Iwase, T.
    Yamada, H.
    Soeki, T.
    Akaike, M.
    Sata, M.
    EUROPEAN HEART JOURNAL, 2009, 30 : 254 - 254
  • [24] Gender-Specific Outcomes after Paclitaxel-Eluting Stent Implantation in Routine Practice
    Lasala, John M.
    Cox, David A.
    Starzyk, Ruth M.
    Uchida, Takahiro
    Dawkins, Keith D.
    Baim, Donald S.
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2009, 53 (10) : A43 - A43
  • [25] Angiographic Restenosis and Clinical Recurrence After Sirolimus- and Paclitaxel-Eluting Stent Implantation
    Vlaar, Pieter J.
    Zijlstra, Felix
    JACC-CARDIOVASCULAR INTERVENTIONS, 2009, 2 (08) : 776 - 778
  • [26] Characterization of target lesion revascularization after TAXUS express paclitaxel-eluting stent implantation
    Ellis, Stephen G.
    Colombo, Antonio
    Grube, Eberhard
    Stone, Gregg W.
    Friedman, Mark
    Baim, Donald S.
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2008, 51 (10) : B16 - B16
  • [27] Neoatherosclerosis after paclitaxel-eluting stent implantation: Ex vivo intravascular image and histopathology
    Kawakami, Rika
    Hao, Hiroyuki
    Tsuchida, Yasu-aki
    Fujino, Akiko
    Imanaka, Takahiro
    Saita, Ten
    Fujii, Kenichi
    Ishihara, Masaharu
    Hirota, Seiichi
    PATHOLOGY INTERNATIONAL, 2017, 67 (01) : 53 - 55
  • [28] Saphenous Vein Graft Aneurysm 10 Years After Paclitaxel-Eluting Stent Implantation
    Tanaka, Akihito
    Jabbour, Richard J.
    Giannini, Francesco
    Latib, Azeem
    Colombo, Antonio
    JOURNAL OF INVASIVE CARDIOLOGY, 2017, 29 (05): : E63 - E63
  • [29] Sirolimus-versus paclitaxel-eluting stent implantation for unprotected left main coronary artery stenosis
    Lee, SH
    Ko, YG
    Jang, J
    Kwon, HM
    Lee, SH
    Yoon, JH
    Park, SH
    Kim, BO
    Jeon, DW
    Yang, JY
    Ryu, SK
    CARDIOLOGY, 2005, 104 (04) : 181 - 185
  • [30] Early- and medium-term outcomes after paclitaxel-eluting stent implantation for sirolimus-eluting stent failure
    Lee, Steve S.
    Price, Matthew J.
    Wong, Garrett B.
    Valencia, Rafael
    Damani, Samir
    Sawhney, Neil
    Gollapudi, Raghava R.
    Schatz, Richard A.
    Teirstein, Paul S.
    AMERICAN JOURNAL OF CARDIOLOGY, 2006, 98 (10): : 1345 - 1348